Search

Your search keyword '"Tieghi A."' showing total 217 results

Search Constraints

Start Over You searched for: Author "Tieghi A." Remove constraint Author: "Tieghi A." Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
217 results on '"Tieghi A."'

Search Results

3. Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib

6. Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib

7. Design of Sinusoidal Leading Edge for Low-Speed Axial Fans Operating under Inflow Distortion

8. P505: GIMEMA AML1819 TRIAL: GEMTUZUMAB OZOGAMICIN PLUS INTENSIVE CHEMOTHERAPY IMPACTS ON THE LEVEL OF POST-CONSOLIDATION MEASURABLE RESIDUAL DISEASE (MRD) IN ACUTE MYELOID LEUKEMIA

9. P1028: MYELOFIBROSIS (MF) TREATED WITH RUXOLITINIB (RUX) MONOTHERAPY: PREDICTORS OF EARLY DISCONTINUATION AND DEATH ON TREATMENT. THE SHORT-TERM RUX PROGNOSTIC MODEL (STR-PM)

10. A Machine Learning Algorithm Applied to Trichoscopy for Androgenic Alopecia Staging and Severity Assessment

11. Incidence, mortality, and survival of hematological malignancies in Northern Italian patients: an update to 2020

20. Effectiveness of a Protocol with Antimicrobial Photodynamic Therapy for Treating Osteoradionecrosis: A Retrospective Study

21. Flash flood prediction in St. Lucia island through a surrogate hydraulic model.

22. Surrogate Modeling of the Aeroacoustics of an NM80 Wind Turbine

23. A Prognostic Model to Predict Ruxolitinib Discontinuation and Death in Patients with Myelofibrosis

25. Cirurgia Guiada para Instalação de Implantes em Paciente Submetido à Radioterapia em Região de Cabeça e Pescoço

26. Predictors of Response to Hydroxyurea and Switch to Ruxolitinib in HU-Resistant Polycythaemia VERA Patients: A Real-World PV-NET Study

27. Risk-adapted MRD-directed therapy for young adults with acute myeloid leukemia: 6-year update of the GIMEMA AML1310 trial

28. Use of Remdesivir in Patients with SARS-CoV-2 Pneumonia in a Real-Life Setting during the Second and Third COVID-19 Epidemic Waves

29. Effectiveness, Tolerability and Prescribing Choice of Antiviral Molecules Molnupiravir, Remdesivir and Nirmatrelvir/r: A Real-World Comparison in the First Ten Months of Use

30. Leading Edge Bumps for Flow Control in Air-Cooled Condensers

31. Characterization of High-Pressure Hydrogen Leakages.

32. Incidence of blast phase in myelofibrosis patients according to anemia severity at ruxolitinib start and during therapy

33. A Case Report of Monkeypox in an Adult Patient from Italy: Clinical and Dermoscopic Manifestations, Diagnosis and Management

34. P1010: RUXOLITINIB IN MYELODEPLETIVE MYELOFIBROSIS: RESPONSE, TOXICITY, AND OUTCOME

35. P1011: PREDICTORS OF COVID-19 DISEASE AND SURVIVAL TO COVID-19 IN MPN PATIENTS TREATED WITH RUXOLITINIB

36. Longitudinal Assessment of Multiple Immunological and Inflammatory Parameters during Successful DAA Therapy in HCV Monoinfected and HIV/HCV Coinfected Subjects

37. Incidence of blast phase in myelofibrosis patients according to anemia severity at ruxolitinib start and during therapy.

38. Aerodynamics and Aeroacoustics of Leading Edge Serration in Low-Speed Axial Fans With Forward Skewed Blades.

40. A Prognostic Model to Predict Ruxolitinib Discontinuation and Death in Patients with Myelofibrosis

41. Steroid use in measles: A retrospective cohort study during the 2017 outbreak in tertiary referral center, Rome and Latina, Italy

42. P505: GIMEMA AML1819 TRIAL: GEMTUZUMAB OZOGAMICIN PLUS INTENSIVE CHEMOTHERAPY IMPACTS ON THE LEVEL OF POST-CONSOLIDATION MEASURABLE RESIDUAL DISEASE (MRD) IN ACUTE MYELOID LEUKEMIA

43. P1028: MYELOFIBROSIS (MF) TREATED WITH RUXOLITINIB (RUX) MONOTHERAPY: PREDICTORS OF EARLY DISCONTINUATION AND DEATH ON TREATMENT. THE SHORT-TERM RUX PROGNOSTIC MODEL (STR-PM)

44. Ruxolitinib in cytopenic myelofibrosis: Response, toxicity, drug discontinuation, and outcome

46. Predictors of Response to Hydroxyurea and Switch to Ruxolitinib in HU-Resistant Polycythaemia VERA Patients: A Real-World PV-NET Study

47. Incidence, mortality, and survival of hematological malignancies in Northern Italian patients: an update to 2020

Catalog

Books, media, physical & digital resources